People: Celgene Corp (CELG.O)
8 Feb 2016
Mr. Mark J. Alles has been promoted as Chief Executive Officer of the Celgene Corporation., effective March 1, 2016. He is no longer President, Chief Operating Officer of Celgene Corp. Mr. Alles joined in April 2004 and served as Vice President, Global Marketing until March 2009 when he became President of the Americas Region. Responsibility for commercial operations in Japan and the Asia Pacific Region was added in July 2011. Mr. Alles previously served as Vice President for the U.S. Oncology Business Unit of Aventis Pharmaceuticals and in other commercial sales and marketing management roles over an 11-year period with Aventis. After earning his B.S. degree from Lock Haven University of Pennsylvania and serving as a Captain in the United States Marine Corps, Mr. Alles started his 27-year career in the pharmaceutical industry at Bayer and worked at Centocor before its acquisition by Johnson & Johnson. Mr. Alles currently serves as a Director for Gilda’s Club NYC, a not-for-profit organization helping people with cancer, and as a trustee of The Healthcare Institute of New Jersey.
|Total Annual Compensation, USD||5,046,080|
|Restricted Stock Awards, USD||901,257|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||2,098,890|
|Fiscal Year Total, USD||8,046,230|